Ophthalmic Packaging Market (2026 - 2033)

Ophthalmic Packaging Market Summary

The global ophthalmic packaging market was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.0 billion in 2026 to USD 3.5 billion in 2033, at a CAGR of 7.9% from 2026 to 2033. The North America market dominated, with a revenue share of approximately 35.0% in 2025. Almond butter is rich in plant-based protein, monounsaturated fats, and antioxidant properties. It is a popular, nutritious alternative for consumers with peanut allergies.

 The rise of health-conscious consumers, particularly in developed economies, has been a major driver of demand for ophthalmic packaging in recent years. The growing need for brand enhancement and differentiation in a highly competitive environment, the development of novel packaging material, and the growing need to adhere to new regulatory guidelines on recycling packaging materials contribute to the market's growth. Major market participants have adapted to changing industry dynamics by implementing innovative strategies to strengthen their market positions. For example, Johnson & Johnson Vision leveraged market slowdowns to enhance engagement with healthcare professionals through training programs focused on its advanced product portfolio.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

This is expected to support long-term brand loyalty and product adoption. Similarly, Carl Zeiss Meditec shifted its focus toward remote care solutions and virtual training initiatives for ophthalmologists. Meanwhile, Alcon is advancing digital transformation in eye care by developing its SMART Suite, a cloud-based platform designed to streamline data management across clinics and operating rooms. The growing integration of telemedicine and digital health solutions into ophthalmic care is expected to create significant growth opportunities for the industry.

The increasing prevalence of ophthalmic conditions such as dry eye syndrome, conjunctivitis, glaucoma, cataracts, and age-related macular degeneration is driving the demand for advanced eye care products and services. This growing disease burden highlights the need for effective treatment options, diagnostic procedures, and drug delivery technologies, which collectively contribute to market expansion.

Moreover, emerging economies, including China, India, and Brazil, offer significant growth opportunities for ophthalmology companies. Contributing factors such as large and aging populations, improving healthcare infrastructure, rising life expectancy, increased healthcare expenditure, and growing disposable incomes are fueling market growth in these regions. These opportunities become particularly important as companies face challenges in mature markets, characterized by slower growth rates, patent expirations, and stricter regulatory requirements.

Drug delivery refers to a wide range of technologies, formulations, and systems designed to transport pharmaceutical compounds safely and effectively to targeted sites within the body. In ophthalmology, the demand for advanced drug-delivery devices is rising due to the increasing prevalence of eye disorders, ongoing technological innovations, growing adoption of personalized treatment approaches, and heightened awareness of eye health. These factors are driving the development of more efficient and patient-friendly drug delivery solutions, which are expected to play a crucial role in market growth over the coming period.

Analyst Perspective

The ophthalmic packaging market has been showing steady growth. It will continue to do so due to the rising incidence of eye disorders and the increasing demand for ophthalmic drugs and eye care products. Also, due to the increased demand for advanced drug delivery systems, there has been a growing requirement for ophthalmic packaging that provides safety. Developing economies like India, China, and Brazil are proving to be a huge potential market, as there has been increased access to healthcare facilities and growing health awareness related to eye care. Regulatory standards and environmental concerns will continue to shape packaging solutions in the market; however, continuous technological improvements and increasing ophthalmic treatment options will drive growth for years to come.

Dose Insights

The market is segmented by dose into single-dose and multidose segments. The multidose segment accounted for the largest revenue share, over 70.0%, in 2025 and is expected to grow at the fastest CAGR during the forecast period. The high penetration index of multidose containers in the OTC market is a key factor fueling the segment growth. In addition, multidose containers are highly patient-compliant and environmentally friendly. It is easier for a patient to carry an eye drop than a single-dose container strip. For instance, in February 2025, Alcon, the world's largest eye care device and pharmaceutical company, announced the launch of “SYSTANE PRO” Preservative-Free Multidose Eye Drops for the U.S., Revolutionizing Dry Eye Relievers.

Multidose packaging is expected to maintain its lead throughout the forecast period due to growing patient demand and the convenience of use. Typically, multidose packaging for liquid ophthalmic products consists of a bottle, dispensing tip or nozzle, cap, and tamper-evident features. Preservatives are used to maintain product quality and avoid microbial contamination.

Single-dose packaging is intended for one-time use of ophthalmic products. Single-dose packaging does not contain preservatives, thus minimizing patients' risk of allergic reactions. The demand for single-dose packaging in eye-related surgeries and for improved healthcare manufacturing facilities is expected to drive growth in the single-dose packaging segment.

Material Insights

The plastic segment accounted for the largest revenue share, at around 50.0%, in 2025 and is expected to grow significantly during the forecast period. Most of the commercially available ophthalmic preparations are packaged in plastic containers. Ease of use, cost-efficiency, and inertness contribute to its rising adoption. For instance, in January 2026, Aptar, one of the world's leading innovators in drug delivery design and manufacturing, reported that its delivery platform supports more than 500 market references worldwide. In this report, they emphasized that their plastic-based ophthalmic dispensing technologies are designed to enhance dose-delivery precision, ease of use for patients, and patient compliance.

The glass segment is expected to grow at the fastest CAGR during the forecast period. The plastic segment is mainly driven by its lower weight, cost-efficiency, and convenience. Certain ophthalmic products, such as eye drops, are packed in entirely plastic dispensers. Most plastic bottles and dispensing tips used for this purpose are made of low-density polyethylene (LDPE) resin. Harder resins, such as polyethylene or polypropylene, are used for the cap. LDPE offers key clinical advantages, such as inertness, flexibility, and decreased chances of contamination. In addition, LDPE is compatible with most resins and formulation compounds; however, its translucency and permeability are among its disadvantages.

Type Insights

The prescription segment accounted for the largest revenue share in 2025, owing to its large-scale use as a first-line treatment. The prescription segment is expected to be driven by an aging global population and advances in drug delivery mechanisms. Prescription medicines are generally used for more complicated ophthalmic diseases, such as glaucoma or severe conjunctivitis.

The OTC segment is expected to grow fastest over the forecast period. Frequent product launches, an increasing number of pharmacies, and growing awareness of self-medication and preventive care are expected to drive the segment.

Severe cases of conjunctivitis and neurotrophic keratitis that are unresponsive to OTC medications are treated using antibiotics. The increasing number of product approvals for various ophthalmic conditions is anticipated to accelerate segment growth. For instance, in October 2025, Glaukos Corporation, a technology-based pharmaceutical company, announced in its press release the approval by the U.S. Food and Drug Administration (FDA) of Epioxa, the first epithelium-on corneal cross-linking for keratoconus.

Regional Insights

North America dominated the ophthalmic packaging market, accounting for the largest revenue share of over 35.0% in 2025, owing to the rising prevalence of ocular disorders, the growing export of ophthalmic products, increasing investment in ophthalmic R&D, and stringent regulatory policies for parametric packaging. For instance, in February 2023, West Pharmaceutical Services announced the expansion of its current collaboration with Corning. This expansion included exclusive rights to distribute Corning Valour glass vials. It also involved launching the company's primary product, West Ready Pack, containing Corning Valour RTU vials.

To learn more about this report, Download Free Sample Report

Asia Pacific Ophthalmic Packaging Market Trends

Asia Pacific is expected to grow at the fastest CAGR during the forecast period owing to the need for speedy and reliable packaging solutions that fulfill a combination of security requirements, enhance patient comfort, comprise tamper-evident technology, and provide high-quality products and product protection. The recent trend of enhanced social security and healthcare systems in Asia is expected to offer new growth opportunities to ophthalmic packaging providers. For instance, in March 2023, SCHOTT launched the production of amber medical glass in India to address rising demand. This initiative extended the availability of borosilicate glass variants to pharma packaging producers in India and Asia.

Key Ophthalmic Packaging Companies Insights

Key market players are adopting strategic initiatives such as mergers & acquisitions, partnerships, product differentiation, product design, and collaborations to gain a competitive edge in the marketplace. For instance, in August 2025, SGD Pharma, a global manufacturer of primary glass packaging for the pharmaceutical industry, announced that it had finalized the acquisition of Alphial S.r.l., an Italian tubular vial and ampoule manufacturer specializing in ready-to-use pharmaceutical packaging.

Key Ophthalmic Packaging Companies

The following key companies have been profiled for this study on the ophthalmic packaging market.

• Amcor Ltd.

• West Pharmaceutical Service Inc.

• Gerresheimer AG

• BD

• Schott AG

• Aptar Group

Recent Developments

• In January 2025, SCHOTT Pharma launched the second generation of its SCHOTT TOPPAC infuse polymer syringe system, including a new tamper-evident cap, functional label technology, and carton-based secondary packaging. The system was designed to enhance the safety of the drugs, their traceability, and sustainability by reducing packaging waste. The project development emphasizes the increasing need in this market for innovation in both the ophthalmic and general pharmaceutical packaging industries.

• In December 2025, Amneal Pharmaceuticals received U.S. FDA approval for Cyclosporine Ophthalmic Emulsion 0.05%, which is a preservative-free ophthalmic preparation in single-use vials. This approval also emphasizes the growing market need for preservative-free and sterile ophthalmic drug packaging formats that enhance safety and stability. This product launch is likely to increase market demand for specialized ophthalmic packaging solutions such as unit-dose and single-use packaging systems.

Global Ophthalmic Packaging Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global ophthalmic packaging market report based on dose, material, type, and region:

To learn more about this report, Download Free Sample Report

• Dose Outlook (Revenue, USD Million, 2021 - 2033)

  • Single dose

  • Multi dose

• Material Outlook (Revenue, USD Million, 2021 - 2033)

  • Glass

  • Plastic

  • Others

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • OTC

  • Prescription

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait